Management of acquired hemophilia A: results from the Spanish registry
Authors:
Open Access
- 14 September 2021
- journal article
- research article
- Published by American Society of Hematology in Blood Advances
- Vol. 5 (19) , 3821-3829
Abstract
The Spanish Acquired Hemophilia A (AHA) Registry is intended to update the status of AHA in Spain. One hundred and fifty-four patients were included and retrospectively followed for a median of 12 months. Patients were predominantly male (56.3%), with median age at diagnosis of 74 years. AHA was more frequently idiopathic (44.1%) and autoimmune disorder-associated (31.7%). Thirty-four percent of patients were on antithrombotic therapy at diagnosis. Hemostatic treatment was used in 70% of patients. Recombinant activated factor VII was more frequently infused (60.3% vs 20.6% activated prothrombin complex concentrate). Only 1 patient did not achieve control of hemorrhage. Complete remission (CR) was achieved by 84.2% of cases after immunosuppressive therapy. Steroids alone were less efficient than the other strategies (68.2% vs 87.2%, P = .049), whereas no differences existed among these (steroids/cyclophosphamide, 88.5%, vs steroids/calcineurin inhibitors, 81.2%, vs rituximab-based regimens, 87.5%). Female sex and high inhibitor levels influenced CR negatively. Thirty-six deaths (23.8%) were reported. Main causes of death were infection (15 patients, 9.9%) and hemorrhage (5 patients, 3.3%). All hemorrhage-related and half the infection-related deaths occurred within 2 months of diagnosis. Prior antithrombotic therapy was inversely associated with survival, irrespective of age. Median age of nonsurvivors was significantly higher (79 vs 73 years in survivors). Patients dying of infection were older than the other nonsurvivors (85 vs 78 years). In summary, fatal infection in the first months is common in our series. Antithrombotic therapy is associated with mortality. Particular care should be taken to avoid misdiagnosis.Keywords
This publication has 27 references indexed in Scilit:
- Outcome of acquired haemophilia in France: the prospective SACHA (Surveillance des Auto antiCorps au cours de l'Hémophilie Acquise) registryHaemophilia, 2013
- Pregnancy‐associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registryBJOG: An International Journal of Obstetrics & Gynaecology, 2012
- Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)Blood, 2012
- Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) RegistryBlood, 2012
- Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)Journal of Thrombosis and Haemostasis, 2012
- Deaths associated with acquired haemophilia in France from 2000 to 2009: multiple cause analysis for best care strategiesHaemophilia, 2011
- Twelve Years of Experience of Acquired Hemophilia A: Trials and Tribulations in South AustraliaSeminars in Thrombosis and Hemostasis, 2009
- The prognosis and treatment of acquired hemophilia: a systematic review and meta-analysisBlood Coagulation & Fibrinolysis, 2009
- International recommendations on the diagnosis and treatment of patients with acquired hemophilia AHaematologica, 2009
- Acquired hemophilia A in the United Kingdom: a 2-year national surveillance study by the United Kingdom Haemophilia Centre Doctors' OrganisationBlood, 2006